Clubbing is out, longevity is in

By Leah Romeo

For decades, youth culture revolved around nightlife; Friday nights meant crowded dance floors and staying out until sunrise. Today, the cultural signals are shifting. Could longevity be the next big thing? 

Across Europe and North America traditional nightlife is struggling, with the number of nightclubs in the UK, for example, dropping from around 1,240 venues in 2020 to roughly 835 in 2024. Similar patterns are visible across Europe, where hundreds of clubs have closed amid rising costs and declining attendance. Younger generations are increasingly prioritising health and wellness: studies of Gen Z consumption habits consistently show lower alcohol consumption compared with previous generations, alongside growing interest in exercise, nutrition and “sober socialising”. 

These cultural changes might seem trivial, but they are part of a broader shift with significant economic implications. While traditional nightlife loses momentum, faced with significant structural pressure, the business of longevity is booming (and attracting a lot of money…).

The economics of living longer

Longevity science is broadly defined as research aimed at slowing the biological processes of ageing or extending healthy lifespan. Recently, it has moved from the abstract of academic curiosity into the concrete of recognised medicine. In 2024 alone, global investment in longevity companies reached about $8.5 billion across more than 300 deals - a sharp increase from the previous year and a sign that institutional investors are beginning to take the sector seriously. 

The underlying logic is straightforward: ageing remains the largest risk factor for many of the most expensive diseases in modern healthcare systems, including cardiovascular disease, cancer and neurodegeneration. If medical research can slow the biological mechanisms associated with ageing, it may be possible to delay multiple diseases simultaneously or see improvements in health span (the number of years people live in good health).

For investors and healthcare systems alike, that makes longevity research increasingly difficult to ignore.

A generational shift in priorities

At the same time, younger generations are reshaping consumer behaviour.

Surveys show that many young adults are going out less frequently and spending less on nightlife than previous generations. In one UK study, 61% of young people reported going out less often, with financial pressures and changing social habits cited as key reasons. Instead, social spending is shifting towards different kinds of experiences: gyms, wellness activities and health-oriented lifestyles.

Some trends illustrate the change clearly. Event organisers report strong growth in “daytime clubbing” and alcohol-free events, while fitness clubs increasingly function as social spaces rather than purely athletic ones. 

From lifestyle trend to investment theme

For investors, the shift matters because it aligns cultural behaviour with a rapidly expanding scientific field. Longevity science spreads across multiple industries: biotechnology, pharmaceuticals, diagnostics, preventative medicine and consumer health technologies. Market forecasts suggest the broader longevity biotechnology sector could grow rapidly over the next decade as new therapies and preventative tools emerge. 

Large research programmes, venture capital funds and pharmaceutical companies are already exploring therapies targeting biological ageing pathways: from senolytic drugs designed to remove damaged cells to regenerative medicine approaches aimed at restoring tissue function. None of this guarantees dramatic breakthroughs in the near term. Longevity science remains complex, and many experimental approaches may fail, but the trajectory is becoming clear.

The new status symbol

For much of the twentieth century, youth culture celebrated excess. Today, the signals are changing: sleep tracking, biological age testing, wearable health technology and personalised nutrition are becoming part of everyday consumer culture – aspirational, even.

In other words, health span is turning into a lifestyle and investment category at the same time. In this context, the rise of longevity investment looks less like a niche biotech story and more like part of a broader societal shift.

Nightlife will not disappear - as humans, we will always gather, celebrate and dance - but both capital and attention seem to be moving elsewhere. For those trying to stay ahead of the next economic shifts, the convergence is hard to ignore.